The Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...

European shares closed largely flat as higher oil prices and renewed US-Iran tensions raised inflation concerns, offsetting stronger euro z...

The National Stock Exchange has successfully gained regulatory approval for its forthcoming initial public offering, marking a significant ...

India now supplies sixty percent of diesel transiting Bab-el-Mandeb to Europe. Russian diesel exports remain severely constrained due to on...

The world’s gold is changing vaults. The Netherlands is shifting bullion to London, France has moved holdings out of New York, while India ...

Karamtara Engineering has set its Rs 875 crore IPO price band at Rs 241-254, with subscription opening September 9. The renewable energy an...

European markets wrapped up the week with a dip, influenced by ongoing Middle East tensions and persistent inflation apprehensions. A posit...

Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...

European shares edged lower on Friday as investors stayed cautious ahead of key U.S. jobs data, while Volkswagen shares jumped 6% after the...

Gland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Ind...

Gland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...

Qualiance International’s Rs 45.11-crore SME IPO opens September 4, with a 43% grey-market premium indicating strong listing expectations. ...

The Indian stock market closed lower Thursday, with Sensex down 417 points and Nifty falling 41 points, pressured by high oil prices, bond ...

Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...

Brown-Forman's first-quarter sales fell short of expectations, yet the company reaffirmed its annual financial goals. Economic worries from...

The company started testing ads in ChatGPT U.S. earlier this year and has steadily expanded to add advertisers ⁠and ⁠tap into more markets,...

Lenskart has emerged from challenger to market leader, with Nomura initiating coverage with a ‘Buy’ rating and Rs 888 target, implying arou...